Shares of Simply Good Foods surged 14.7% to $14.73 after the nutritional snack maker reported fiscal Q3 2026 results that topped Wall Street's deeply lowered expectations on both earnings and revenue, despite a 6.3% year-over-year net sales decline. The rally — the stock's biggest single-day move in months — says less about a turnaround and more about how bad things were expected to be.
Wall Street Braced for Disaster, and Got Something Slightly Better. Analysts had penciled in just $0.35 per share in adjusted earnings and roughly $332.6 million in revenue.
That $0.35 consensus was itself the product of a brutal downward slide — three months ago, the Street was modeling $0.57, a cut of nearly 40%. Coming in above such a deflated bar gave shorts and pessimists a reason to cover. But a beat against lowered estimates is not the same as a healthy business.
Atkins Is Still Sinking and Dragging the Portfolio Down. In the prior quarter, Atkins revenue fell 26.6% , and the brand's decline remains the company's heaviest anchor. Management took a $249 million non-cash write-down on Atkins and OWYN brand value last quarter , effectively admitting the brands are worth far less than what was paid. The CEO blamed product quality issues and poor marketing execution — problems that don't fix themselves in one quarter. Investors are betting that Quest, the protein-bar brand, and OWYN, a plant-based shake line, can carry the whole company. But that's a lot of weight on two brands while the third is in free fall.
The Margin Picture Remains Under Pressure. Management's revised full-year guidance calls for net sales of $1.31–$1.35 billion (down 7–10% year-over-year) and adjusted EBITDA of $217–$225 million (down 19–22%).
Gross margins contracted 460 basis points to 31.6% last quarter, driven by cocoa inflation and tariffs. Even with some cocoa cost relief expected in the back half, profitability is declining faster than sales.
A Stock Still Far from Recovery. The 52-week range spans $10.21 to $34.19 , meaning at $14.73 the stock sits barely a third of the way back from its lows. The market cap is roughly $1.2 billion with trailing earnings per share still negative at –$1.13 due to the impairment charge. The average analyst price target is $17.33 , leaving modest upside — but only if execution improves. Today's pop rewards survival, not strength.